Stay updated on Tagraxofusp in Secondary AML Clinical Trial
Sign up to get notified when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.

Latest updates to the Tagraxofusp in Secondary AML Clinical Trial page
- CheckyesterdayChange DetectedThe Record History now includes a new latest revision entry (v3.5.4) and removes the previous revision (v3.5.3) from the history list.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s revision identifier changes from **v3.5.2** to **v3.5.3**, indicating an update to the record-history page tooling/label rather than a modification of the clinical trial’s record details.SummaryDifference0.1%

- Check30 days agoChange DetectedA new revision entry v3.5.2 was added to the history, replacing the prior v3.5.0. The previous revision v3.5.0 was removed.SummaryDifference0.1%

- Check37 days agoChange DetectedNew version entry dated 2026-04-08 adds Study Status updates; the history entry dated 2026-01-23 has been removed.SummaryDifference0.3%

- Check58 days agoChange DetectedA new revision entry v3.5.0 was added to the Record History, and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check66 days agoChange DetectedAdded Revision: v3.4.3 to the record history and removed Revision: v3.4.2 from the history.SummaryDifference0.1%

Stay in the know with updates to Tagraxofusp in Secondary AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tagraxofusp in Secondary AML Clinical Trial page.